Johnson & Johnson (JNJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2004 | 09-2004 | 06-2004 | 03-2004 | 12-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 8,180,000 | 7,292,000 | 4,951,000 | 2,493,000 | 7,197,000 |
| Depreciation Amortization | 2,124,000 | 1,506,000 | 1,027,000 | 502,000 | 1,869,000 |
| Income taxes - deferred | -676,000 | -424,000 | -429,000 | -191,000 | -720,000 |
| Accounts receivable | -108,000 | -384,000 | -622,000 | -251,000 | -685,000 |
| Other Working Capital | 936,000 | 278,000 | -768,000 | -149,000 | 1,331,000 |
| Other Operating Activity | 633,000 | 402,000 | 622,000 | 251,000 | 1,603,000 |
| Operating Cash Flow | $11,089,000 | $8,670,000 | $4,781,000 | $2,655,000 | $10,595,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,938,000 | -907,000 | -481,000 | -243,000 | -1,927,000 |
| Net Acquisitions | -580,000 | -330,000 | -300,000 | N/A | -2,812,000 |
| Purchase Of Investment | -11,617,000 | -9,121,000 | -5,654,000 | -3,103,000 | -7,590,000 |
| Sale Of Investment | 12,061,000 | 7,508,000 | 4,684,000 | 2,512,000 | 8,062,000 |
| Other Investing Activity | -273,000 | -91,000 | -113,000 | -16,000 | -259,000 |
| Investing Cash Flow | $-2,347,000 | $-2,941,000 | $-1,864,000 | $-850,000 | $-4,526,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 514,000 | 313,000 | 332,000 | 147,000 | 3,062,000 |
| Debt Issued | 17,000 | 16,000 | 16,000 | 19,000 | 1,023,000 |
| Debt Repayment | -395,000 | -1,000 | -1,000 | 1,000 | -196,000 |
| Common Stock Issued | 684,000 | 434,000 | 311,000 | 125,000 | 311,000 |
| Common Stock Repurchased | -1,384,000 | -985,000 | -760,000 | -407,000 | -1,183,000 |
| Dividend Paid | -3,251,000 | -2,404,000 | -1,559,000 | -713,000 | -2,746,000 |
| Other Financing Activity | -1,291,000 | -1,114,000 | -911,000 | -675,000 | -4,134,000 |
| Financing Cash Flow | $-5,106,000 | $-3,741,000 | $-2,572,000 | $-1,503,000 | $-3,863,000 |
| Exchange Rate Effect | 190,000 | -17,000 | -41,000 | -42,000 | 277,000 |
| Beginning Cash Position | 5,377,000 | 5,377,000 | 5,377,000 | 5,377,000 | 2,894,000 |
| End Cash Position | 9,203,000 | 7,348,000 | 5,681,000 | 5,637,000 | 5,377,000 |
| Net Cash Flow | $3,826,000 | $1,971,000 | $304,000 | $260,000 | $2,483,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 11,089,000 | 8,670,000 | 4,781,000 | 2,655,000 | 10,595,000 |
| Capital Expenditure | -2,175,000 | -1,142,000 | -714,000 | -292,000 | -2,262,000 |
| Free Cash Flow | 8,914,000 | 7,528,000 | 4,067,000 | 2,363,000 | 8,333,000 |